thiophenes has been researched along with Eaton-Lambert Myasthenic Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frasso, M; Garcia-Ocano, A; Lacomis, D; Liang, M; Malick, W; Meriney, SD; Reddel, SW; Tarr, TB; Valdomir, G; Wipf, P | 1 |
| Frasso, M; Lacomis, D; Liang, M; Meriney, SD; Reddel, SW; Tarr, TB; Valdomir, G; Wipf, P | 1 |
| Liang, M; Meriney, SD; Tarr, TB; Valdomir, G; Wipf, P | 1 |
3 other study(ies) available for thiophenes and Eaton-Lambert Myasthenic Syndrome
| Article | Year |
|---|---|
Evaluation of a novel calcium channel agonist for therapeutic potential in Lambert-Eaton myasthenic syndrome.
Topics: Action Potentials; Adult; Aged; Animals; Calcium Channel Agonists; Cell Line; Cyclin-Dependent Kinases; Data Interpretation, Statistical; Electrophysiological Phenomena; Humans; Lambert-Eaton Myasthenic Syndrome; Mice; Mice, Transgenic; Middle Aged; Neuromuscular Junction; Neurotransmitter Agents; Patch-Clamp Techniques; Phosphotransferases; Purines; Roscovitine; Thiophenes | 2013 |
Complete reversal of Lambert-Eaton myasthenic syndrome synaptic impairment by the combined use of a K+ channel blocker and a Ca2+ channel agonist.
Topics: 4-Aminopyridine; Amifampridine; Animals; Calcium Channel Agonists; Cell Line, Tumor; Drug Synergism; Female; Humans; Lambert-Eaton Myasthenic Syndrome; Mice; Neuromuscular Junction; Potassium Channel Blockers; Purines; Synaptic Potentials; Thiophenes | 2014 |
New calcium channel agonists as potential therapeutics in Lambert-Eaton myasthenic syndrome and other neuromuscular diseases.
Topics: Calcium Channel Agonists; Humans; Lambert-Eaton Myasthenic Syndrome; Neuromuscular Diseases; Purines; Roscovitine; Thiophenes | 2012 |